Genomics are important in determining cost effectiveness because they ensure that the right agents are being used on the patients for which the treatment was intended, explained Renee JG Arnold, PharmD, RPh, practice lead for health economics and outcomes research at Quorum Consulting, Inc.
Genomics are important in determining cost effectiveness because they ensure that the right agents are being used on the patients for which the treatment was intended, explained Renee JG Arnold, PharmD, RPh, practice lead for health economics and outcomes research at Quorum Consulting, Inc.
What is the role and importance of genomics during cost effectiveness discussions?
Well, when we’re talking about mutations that are more likely to demonstrate a better health outcome for a particular patient rather than using an expensive medication across the board. Here, genomics helps you target what would be an appropriate medication for a particular person, and so you’re more likely to get a cost effective outcome, if you will, if you’re targeting a patient with the mutation for which that agent is meant.
What is budgetary impact modeling and how is it used within specialty pharmacy?
Generally, when you’re doing budgetary impact modeling it’s more of a policy analysis, and typically you’ll look for a market mix, if you will, of different kinds of therapeutic options for a patient with a particular disease. And you’ll look to see how that mix may change over time and what that will do to, let’s say for example, the pharmacy budget. And so it’s really essential to look at this budgetary impact and see over time what’s the prevalence of the disease, what’s the incidence of the disease, and over what period of time will the patient require therapy.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More
Getting to Know Dr Shauna Downs, Public Health Nutritionist
February 23rd 2024Shauna Downs, PhD, MS, is an associate professor in the Department of Health Behavior, Society, and Policy at the Rutgers School of Public Health. A former figure skater, her research now focuses on interventions to promote healthy and sustainable food choices and exploring how our changing climate, food systems, diet, and nutrition are inextricably linked.
Read More